Keywords: amgen, sensipar, oked, fda, world, biotechnology, leader

Amgen's Sensipar OKed by FDA

Article | 15 March 2004

World biotechnology leader Amgen has received US Food and Drug Administration approval for its Sensipar (cinacalcet), following a priority review. ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Amgen

Go to company listing

Related Drugs

cinacalcet

Sensipar

Nystatin

Go to drug listing